ACT Genomics

8 articles about ACT Genomics

• Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

  12/16/2022

  Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that it is acquiring a majority stake in ACT Genomics Holdings Company Limited (“ACT”), an Asia based genomics company specializing in precision oncology with operations in Hong Kong, Taiwan, Japan, Singapore, Thailand and in the UK.

• Cerba Research and ACT Genomics Announce Strategic Joint Venture — CerbACT Asia

  8/24/2021

  Cerba Research announced today that they have joined forces with ACT Genomics under a joint venture model to create a purpose-built lab facility in Taiwan covering the Asia Pacific region.

• ACT Genomics ("ACTG") Completed the First Closing of latest Round of Equity Financing

  9/7/2020

  ACT Genomics is pleased to announce the completion of the first closing of the latest round of equity financing from a group of strategic investors including Aflac Ventures LLC and Kyoto University Innovation Capital.

• ACT Genomics completed investment on route to become the leading DNA sequencing-based cancer solution provider in Asia

  9/26/2018

  ACT Genomics Holdings Company Limited is pleased to announce the completion of the latest round of equity financing.

• ACT Genomics, Astra Enter Collaboration for BRCA Testing in Singapore and Taiwan

  2/2/2018

  ACT Genomics is honored to collaborate with AstraZeneca Singapore for both somatic and germline genetic testing of BRCA in patients with ovarian cancer, using the advanced next generation sequencing.

• ACT Genomics Raises $12.5 Million For Genomic Oncology Testing

  5/12/2016

• ACT Genomics Bags $12.5 Million Series B

  5/6/2016

• ACT Genomics Receives CAP Accreditation, Offering Full-Scale And Comprehensive Clinical Services To Transform Cancer Care

  4/18/2016